Visceral adiposity and insulin resistance
Typical setting: Central weight gain is strongly associated with type 2 diabetes risk.
Adipose inflammation and altered lipid handling impair insulin signalling in liver, muscle, and fat.
T2DM module
Understand type 2 diabetes as insulin resistance plus beta-cell failure, linking hyperglycaemia to vascular, renal, nerve, and treatment priorities.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Type 2 diabetes usually reflects several pressures acting on insulin sensitivity and beta-cell reserve.
Typical setting: Central weight gain is strongly associated with type 2 diabetes risk.
Adipose inflammation and altered lipid handling impair insulin signalling in liver, muscle, and fat.
Typical setting: Family history and ethnicity influence risk.
Inherited differences affect beta-cell reserve, insulin secretion, and insulin sensitivity.
Typical setting: Physical inactivity reduces one of the body's major routes for glucose disposal.
Skeletal muscle becomes less effective at clearing glucose after meals.
Typical setting: Risk rises with age, although younger onset is increasingly common.
Beta cells may become less able to compensate for insulin resistance over time.
Typical setting: Glucocorticoids, atypical antipsychotics, Cushing syndrome, and other states can worsen glucose handling.
Counter-regulatory hormone effects increase hepatic glucose output and insulin resistance.
Mechanism chain
The disease is best understood as a mismatch between insulin demand and beta-cell supply.
Muscle takes up less glucose, the liver continues producing glucose despite insulin, and adipose tissue releases more fatty acids.
More insulin is secreted to hold glucose down, so insulin levels may be high before diabetes is diagnosed.
Keep exploring